Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature.

@article{Drolet2018ModelCO,
  title={Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature.},
  author={Mélanie Drolet and {\'E}lodie B{\'e}nard and Mark Jit and Raymond C W Hutubessy and Marc Brisson},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2018},
  volume={21 10},
  pages={
          1250-1258
        }
}
  • M. Drolet, Élodie Bénard, M. Brisson
  • Published 24 May 2018
  • Medicine, Political Science
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Figures and Tables from this paper

An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines
TLDR
Though most studies were critically low quality and had a low quality of reporting, the human papillomavirus vaccine was consistently cost effective in young girls and men who have sex with men.
Guidelines for multi-model comparisons of the impact of infectious disease interventions
TLDR
These guidelines should help researchers plan, conduct and report model comparisons of infectious diseases and related interventions in a systematic and structured manner for the purpose of supporting health policy decisions.
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects
TLDR
A substantial positive impact of RVV on RVGE disease burden with a very low risk of intestinal intussusception for up to 7 days after RVV has been documented in the AP regions, and economic evaluation studies predict a significant reduction in treatment costs related to RVGE and its complications showing that RVV is good value for money.
Cost-effectiveness of emergency preparedness measures in response to infectious respiratory disease outbreaks: a systematic review and econometric analysis
TLDR
The cost analysis results provide evidence to policymakers on the cost-effectiveness of pharmaceutical and non-pharmaceutical intervention strategies which may be applied to mitigate or respond to infectious respiratory disease outbreaks.
The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic
TLDR
Key limitations of mathematical modeling as a tool for interpreting empirical data and informing individual and public decision making are reviewed and several approaches that have been used to strengthen the validity of inferences drawn from these analyses are presented.
An approach for improving the quality of country-level TB modelling
TLDR
A benchmarking, reporting, and review approach and accompanying tools to allow constructive review of country-level TB modelling applications that provides independent evaluation of the appropriateness of modelling decisions during the course of an application, allowing meaningful changes to be made before results are used to inform decision-making.
...
...

References

SHOWING 1-10 OF 158 REFERENCES
Cost-Effectiveness Analyses of Hepatitis A Vaccine
TLDR
Overall, analyses that evaluated the combined hepatitis A/hepatitis B vaccine, adjusted incidence for under-reporting, included societal costs and that came from studies of higher methodological quality tended to have more attractive cost-effectiveness ratios.
A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus
TLDR
A critical review of cost-effectiveness analyses of HPV vaccination in males was conducted and nine studies were identified in different countries and there was a general lack of transparency to fully describe the details of the methodological approach of modeling and calibration.
Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine
TLDR
A qualitative systematic review of studies using mathematical modelling to determine the effectiveness or cost effectiveness of an HPV vaccine compared with the current cytology-based Pap smear screening programme found all studies showed that vaccination would decrease rates of HPV infection, precancerous lesions and cervical cancer.
ECONOMIC EVALUATIONS OF PNEUMOCOCCAL VACCINATION STRATEGIES IN ADULTS. A SUMMARY OF THE RESULTS.
TLDR
P pneumococcal vaccination of the elderly aged between 65 and 75 years is found to be relatively cost-effective for the health care payer and there is also evidence that vaccination of HIV+ patients and of young military personnel may be justifiable on the basis of economic evaluation including direct medical costs only.
Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries
TLDR
This review consists of cost-effectiveness studies published in the peer-reviewed literature before August 2008 and concludes that vaccinating young girls against HPV is likely to be cost- effective and vaccinating boys when coverage rates are low and catch-up strategies have reached conflicting conclusions.
Is vaccination against hepatitis B efficient? A review of world literature.
TLDR
A study aimed at assessing the variability of assumptions upon which economic models for the introduction of vaccination against Hepatitis B are based found profound variability, and there is an urgent need to standardise study methods and define a common set of procedures.
A critical literature review of health economic evaluations of rotavirus vaccination
TLDR
New evidence on the vaccination effectiveness in real-world, new ways of modeling herd protection and assessments of QoL in children could help more precisely define the conditions under which RV vaccination would be cost-effective in developed countries.
...
...